(Press-News.org) Contact information: Dr. Salvador Macip
sm460@le.ac.uk
01-162-297-113
University of Leicester
Breakthrough announced in treatment of patient with rare type of leukemia
University of Leicester researchers deploy 'precision medicine' to successfully target advanced form of leukaemia with skin cancer drug
A team of scientists from the University of Leicester has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a rare type of blood cancer, using a drug administered to combat skin cancer.
The research, which is published today (Thursday 16 January) in the New England Journal of Medicine, indicates Vemurafenib, a BRAF inhibitor that has been approved as a treatment for advanced melanomas, is also successful in treating leukaemia. The study shows the treatment, which can be taken orally, cleared the malignant cells from the patient's blood and led to a complete clinical recovery in a number of days.
The study was led by the University of Leicester and involved treatment of a patient at the Leicester Royal Infirmary.
Dr Salvador Macip, from the University of Leicester's Department of Biochemistry, explained: "A genetic study of the patient's blood cells allowed us to identify a mutation in the BRAF gene that is commonly found in skin cancers. This knowledge enabled us to combat the cancer cells with Vemurafenib, which has had proven success as a BRAF inhibitor in melanomas, and showed similar success for this patient who had exhausted all other treatment options, which is fantastic.
"What was most surprising was that the drug did not work in the way we expected it to. Whilst it successfully blocked BRAF and killed the cancerous cells, there was no ability to block the downstream cascade of signals. Therefore more research is required to better understand how this drug works to ensure we are able to use it in the best possible way.
"This is one of the first clinical examples of this treatment for HCL and we are the first researchers to do a biochemical study of the samples and discover that the drug does not do what it's supposed to be doing."
This approach to targeting cancer is an example of precision medicine with clinicians and research scientists working side-by-side to ensure the best treatment, tailored to the individual patient, was provided.
Professor of Haemato-Oncology at the University of Leicester, Professor Martin Dyer, who is Honorary Consultant Physician, Department of Haematology at Leicester's Hospitals, said: "Precision medicine in which clinicians and basic scientists collaborate to deliver novel and rapid personalised therapies to cancer patients like this is essential.
"We drew blood from the patient on a daily basis which was analysed back in the lab to monitor the effects of the drug. The more understanding we have of how treatments such as Vemurafenib kill cancer cells, the more effective and targeted treatments can be."
Professor Dyer is based in the University of Leicester's Department of Cancer Studies and Molecular Medicine and the treatment of the patient took place at the Leicester Royal Infirmary.
This research shows that drugs currently used to target certain cancers could be applied in other malignancies that share similar genetic backgrounds.
University of Leicester Pro-Vice-Chancellor and Head of the College of Medicine, Biological Sciences and Psychology, Professor David Wynford-Thomas, said: "The importance of the close working partnership between the University of Leicester and Leicester's Hospitals is highlighted in advances such as this. World-class research at the University brings direct benefits to patients in Leicester's hospitals in diverse areas including cardiovascular health, kidney research, lung health, diabetes, cancer research and many other areas.
"I am delighted that our research has had such a direct benefit locally - it is another first for the University of Leicester and Leicester Royal Infirmary."
INFORMATION:
Breakthrough announced in treatment of patient with rare type of leukemia
University of Leicester researchers deploy 'precision medicine' to successfully target advanced form of leukaemia with skin cancer drug
2014-01-16
ELSE PRESS RELEASES FROM THIS DATE:
A deeper look at interfaces
2014-01-16
A deeper look at interfaces
Researchers at Berkeley Lab's Advanced Light Source develop new technique for probing subsurface electronic structure
"The interface is the device," Nobel laureate Herbert Kroemer famously observed, referring to the remarkable ...
Trees grow faster and store more carbon as they age
2014-01-16
Trees grow faster and store more carbon as they age
Trees put on weight faster and faster as they grow older, according to a new study in the journal Nature. The finding that most trees' growth accelerates as they age suggests that large, old trees may ...
2 diabetes studies in Jan. 2014 Health Affairs
2014-01-16
2 diabetes studies in Jan. 2014 Health Affairs
Jan. articles examine the toll of diabetes, both in the US and abroad
Poorer Americans: depleted food budgets can mean higher risk of hypoglycemia.
For generations, economists have noted that low-income households spend much ...
Researchers discover that coevolution between humans and bacteria reduces gastric cancer risk
2014-01-16
Researchers discover that coevolution between humans and bacteria reduces gastric cancer risk
Research carried out in two distinct communities in Colombia illustrates how coevolution between humans and bacteria can affect a person’s risk ...
New analysis shows fewer years of life lost to cancer
2014-01-16
New analysis shows fewer years of life lost to cancer
Dartmouth researchers say US has underestimated its progress in war on cancer
(Lebanon, NH, 1/15/14) - Since the enactment of the National Cancer Act in 1971, the U.S. has spent hundreds ...
Ray of hope for magazines in digital era
2014-01-16
Ray of hope for magazines in digital era
Targeted audiences and websites can help magazines weather the onslaught of online competition
There is a ray of hope for magazines that do it right.
While print media continue to suffer at the hands of their online counterparts, ...
Resisting the flu
2014-01-16
Resisting the flu
New avenues for influenza control suggested by identification of an enzyme that plays a crucial role in resistance to the infection
McGill researchers, led by Dr. Maya Saleh of the Department of Medicine, have identified an enzyme, cIAP2 that helps the ...
Next-gen reappraisal of interactions within a cancer-associated protein complex
2014-01-16
Next-gen reappraisal of interactions within a cancer-associated protein complex
Application of global sequencing technology reveals how an activator of gene expression stays focused
KANSAS CITY, MO- At a glance, DNA is a rather simple sequence of A, ...
Hugging hemes help electrons hop
2014-01-16
Hugging hemes help electrons hop
Novel biological mechanism relays electrons in proteins in mineral-breathing bacteria important for energy-related research
RICHLAND, Wash. -- Researchers simulating how certain bacteria run electrical current ...
Nationwide minimally invasive surgery rates triple for pancreatic disease
2014-01-16
Nationwide minimally invasive surgery rates triple for pancreatic disease
Researchers at University of California, San Diego School of Medicine report a three-fold increase in the use of minimally invasive surgery (MIS) across the nation for patients ...
LAST 30 PRESS RELEASES:
Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid
Low LDL cholesterol levels linked to reduced risk of dementia
Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients
Almost one in ten people surveyed report having been harmed by the NHS in the last three years
Enhancing light control with complex frequency excitations
New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients
New insight into factors associated with a common disease among dogs and humans
Illuminating single atoms for sustainable propylene production
New study finds Rocky Mountain snow contamination
Study examines lactation in critically ill patients
UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award
Doubling down on metasurfaces
New Cedars-Sinai study shows how specialized diet can improve gut disorders
Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana
PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation
ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy
How VR technology is changing the game for Alzheimer’s disease
A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet
Balance between two competing nerve proteins deters symptoms of autism in mice
Use of antifungals in agriculture may increase resistance in an infectious yeast
Awareness grows of cancer risk from alcohol consumption, survey finds
The experts that can outsmart optical illusions
Pregnancy may reduce long COVID risk
Scientists uncover novel immune mechanism in wheat tandem kinase
Three University of Virginia Engineering faculty elected as AAAS Fellows
Unintentional drug overdoses take a toll across the U.S. unequally, study finds
A step toward plant-based gelatin
ECMWF unveils groundbreaking ML tool for enhanced fire prediction
The food and fuel that farms itself
Patient- and Community-Level Characteristics Associated With RSV Vaccination
[Press-News.org] Breakthrough announced in treatment of patient with rare type of leukemiaUniversity of Leicester researchers deploy 'precision medicine' to successfully target advanced form of leukaemia with skin cancer drug